![JCM | Free Full-Text | Comparative Assessment and External Validation of Hepatic Steatosis Formulae in a Community-Based Setting JCM | Free Full-Text | Comparative Assessment and External Validation of Hepatic Steatosis Formulae in a Community-Based Setting](https://www.mdpi.com/jcm/jcm-09-02851/article_deploy/html/images/jcm-09-02851-g004.png)
JCM | Free Full-Text | Comparative Assessment and External Validation of Hepatic Steatosis Formulae in a Community-Based Setting
![FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study - The Lancet Gastroenterology & Hepatology FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/d756cedc-413f-4b5e-a1d0-b52ee0200833/gr1.gif)
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study - The Lancet Gastroenterology & Hepatology
![The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-93435-x/MediaObjects/41598_2021_93435_Fig2_HTML.png)
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports
![The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-93435-x/MediaObjects/41598_2021_93435_Fig1_HTML.png)
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports
![The Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index (ANI) - Medical Professionals - Mayo Clinic The Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index (ANI) - Medical Professionals - Mayo Clinic](https://www.mayoclinic.org/-/media/kcms/gbs/medical-professionals/images/2022/07/08/15/33/nafld-progression-767x535.jpg)
The Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index (ANI) - Medical Professionals - Mayo Clinic
![Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers - Mayo Clinic Proceedings Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers - Mayo Clinic Proceedings](https://www.mayoclinicproceedings.org/cms/asset/f31fe019-b030-441a-ae05-df37b814e8c8/figs1.jpg)
Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers - Mayo Clinic Proceedings
![Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Frontline Gastroenterology Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Frontline Gastroenterology](https://fg.bmj.com/sites/default/files/highwire/flgastro/5/3.cover-source.jpg)
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Frontline Gastroenterology
![Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment](https://www.frontiersin.org/files/Articles/615978/fmed-08-615978-HTML/image_m/fmed-08-615978-g001.jpg)
Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
![Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches](https://pub.mdpi-res.com/diagnostics/diagnostics-12-00407/article_deploy/html/images/diagnostics-12-00407-g001-550.jpg?1644571167)
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
![Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/355d73f6-ab09-4fef-b4e9-0083ef9bb5d3/hepr13688-fig-0001-m.jpg)